The Effect of Vitamin C on Tetanus Toxin and Strychnine Toxicity: a Systematic Review of Animal Studies

by Harri Hemilä



Department of Public Health
University of Helsinki,  Helsinki, Finland
harri.hemila@helsinki.fi
Home:  http://www.mv.helsinki.fi/home/hemila
This file:
http://www.mv.helsinki.fi/home/hemila/CT/tetanus.htm 

Version May 29, 2012

     

Contents

  1. Introduction
  2. Methods
  3. Results of the studies
  4. Discussion
  5. References
  6. Table 1: Vitamin C and Tetanus Toxin
  7. References to Table 1
  8. Table 2: Vitamin C and Strychnine
  9. References to Table 2
  10. Table 3: Effect of the interval between vitamin C administration and strychnine administration (Dey 1967)
  11. References to Table 3


Introduction

Tetanus is a disease caused by the toxin of Clostridium tetani, which may contaminate wound (see summaries eg.    CDC_2008A   CDC_2008B   CDC 2008 Fig   Todar's Textbook  Wisconsin Bact ).

In a controlled trial, Jahan et al. (1984) found that 1 g/day vitamin C significantly reduced the mortality of tetanus patients in Bangladesh. Although Jahan's trial was methodologically unsatisfacory compared with current standards, the shortcomings do not give an evident explanation to the differences between the vitamin C and control groups (Hemilä & Koivula 2008).  Nevertheless, there are no studies with human patients giving independent support to the proposal that vitamin C might have an effect on tetanus. Indirect support to the effects of vitamin C can be obtained from animal studies.

A large number of animal studies have found that vitamin C protects against diverse viral, bacterial and protozoal infections (see p. 7-9 and 105-118 in Hemilä (2006)).  Consequently, it is possible that vitamin C affects the immune system so that it is reflected as changes in the incidence and severity of infections. Nevertheless, it is also possible that vitamin C has non-immunologic effects against infections.  A number of animal studies found that vitamin C protects against the harms caused by purified bacterial toxins: diphtheria toxin (Harde 1934; Lyman & King 1936; Harris et al. 1937; Ghosh 1939a, Torrance 1940) and endotoxin (Torrance 1940; Garcia et al. 1990; Rojas et al. 1996; Benito & Bosch 1997; Yamaguchi et al. 1997; Armour et al. 2001; Victor et al. 2002).  The action of vitamin C against the acute effects of bacterial toxins suggests that the effecs of vitamin C are not restricted to protection against viable bacteria.  Furthermore, in guinea pigs, 0.5 MLD tetanus toxin reduced in 3 days the level of vitamin C in plasma by 44% (50/89), in adrenals by 22% (333/428), in kidney by 20% (77/97) and in the liver by 19% (568/696) (Ghosh 1939b).  

In tetanus patients, blood vitamin C level is about half the level of normal controls (Chakrabarti & Bannerjee 1955, 1956). Furthermore, Chakrabarti & Bannerjee (1955) reported that among the tetanus patients, vitamin C levels were lower in those who later succumbed compared with those who survived, suggesting that the low level of vitamin C may be associated with the prognosis of the disease.  Finally, the blood level of dehydroascorbte, oxidized form of vitamin C, is very low in normal controls but in tetanus patients it is higher in patients with more severe disease (Chakrabarti & Bannerjee 1955).  Thus, tetanus seems to affect vitamin C metabolism in humans.

Strychnine and tetanus have similar neurophysiological effects, and because of the similarity of the symptoms, strychnine poisoning is a differential diagnosis of tetanus ().

The purpose of this systematic review is to summarize the findings of animal studies which have examined the effect of vitamin C on the effects of tetanus toxin and strychnine on animals.


Methods

Previously, extensive literature searches were carried out to find out studies that have examined the effect of vitamin C on human and animal infections (p. 20 in Hemilä 2006).  The literature searches were composed of several searches using various strategies in different databases (Medline, Web of Science, Chemical Abstracts, Biological Abstracts). In some cases the search phrases were rather loose, e.g., ‘vitamin C’ alone, whereas some other searches were limited by additional phrases such as ‘infection’ or ‘immune.’ Papers citing the older seminal papers were sought in the citation data base (Web of Science). Thus, no single or simple explicit search strategy was used.  For this report, additional searches, using the search terms "vitamin C"/ascorb* AND tetanus/strychnine, were carried out with modifications needed to the data bases.  Old reports were scanned and are available via links of this document.  Studies which reported a controlled comparison between vitamin C and control groups are presented in the tables: the effect of vitamin C on tetanus toxin (Table 1), on strychnine (Tables 2 and 3). 

In studies with dichotomous data (2×2 tables), the mid-P was calculated.  The rationalization of the mid-P modification of the Fisher exact test is described on p. 20-21 of Hemilä (2006) and survival data was analyzed using the logrank test (see eg BMJ  Wikipedia). LD50 (lethal dose for 50% of animals) and ED50 (effective dose for 50% of animals) calculation were carried out using SAS program PROBIT.

One-tailed P-values are used in this report, because the question is whether vitamin C decreases the severity of disease or not, and this questions are unidirectional. A benefit of the 1-tailed P-value is that it shows the direction of the difference, with P>0.5 indicating the direction of harm.  The 1-tailed P-value can easily be transformed to the 2-tailed P-value. 


Results of the studies

Three series of studies examined the effect of vitamin C against the toxicity of tetanus toxin in rats (Table 1). Dey (1966) reported that vitamin C prevented mortality caused by tetanus toxin when vitamin C was administered either before or shortly after the toxin. Eichbaum (1977) found significant benefit of vitamin C against short term effects of tetanus toxin, but the difference in longer term mortality was nonsignificant. Frezza (1957) used two doses of vitamin C and two doses of tetanus toxin and vitamin C was significantly beneficial only in the combination of low dose toxin and high dose vitamin C.  Thus, Frezza's results suggest that the ratio of vitamin C dose to the toxin dose may be crucial. Ghosh (1938) studied the effect of vitamin C against tetanus toxin toxicity in guinea pigs, and found a marginally significant benefit only in one comparison (Table 1).

Three series of experiments have examined the effect of vitamin C against strychnine toxicity in mice (Table 2). Dey (1965) found that high dose vitamin C totally prevented strychnine toxicity.  In the second series, Dey (1967) used a fixed dose of strychnine and varied the dose of vitamin C over a wide range. In the absence of vitamin C, all mice died, whereas with the highest vitamin C doses, all mice survided. Based on Dey's data, the ED50 dose in mice is 76 mg/kg (95% CI: 19-149 mg/kg) for the protection against 2 mg/kg strychnine.

Eichbaum et al. (1977) varied strychnine dose in mice with and without high dose vitamin C. Based on Eichbaum's data, the LD50 value without vitamin C is 0.88 mg/kg (95% CI: 0.78-0.99 mg/kg), whereas the LD50 value was close to two times as high in animals administered high dose of vitamin C, 1.50 mg/kg (95% CI: 1.33-1.70 mg/kg).  The difference between these LD50 values is statistically highly significant.

Jahan et al. (1984) studied the effect of vitamin C in chickens with two strychnine doses. In chickens administered the lower dose of strychnine, vitamin C prevented stretching of the wings. In chickens aministered the higher strychnine dose, vitamin C significantly prevented mortality.

In two studies with fish, Eichbaum et al. (1977) found that vitamin C prevented strychnine toxicity.

Dey (1967) examined the relationship between the protection against strychnine toxicity and the level of vitamin C in plasma, so that strychnine was administered 15 min to 2 hours after the vitamin (Table 3). Strychnine administered soon after high dose vitamin C did not lead to mortality, whereas strychnine administered 2 hours after vitamin C killed all mice.  The effect of strychnine correlated with plasma vitamin C level, so that definite protection against strychnine toxicity occurred only when vitamin C plasma level was about 2 mg/100 ml (120 µmol/l).

Discussion

Only one of the identified experimental series failed to record an unambiguous benefit of vitamin C, namely the study by Ghosh (1938). Three series suggested dose-response by the variation of the dose of vitamin C (Dey 1967) or strychnine (Eichbaum 1977) or both vitamin C and tetanus toxin (Frezza 1957) so that a higher ratio of vitamin C to toxin led to a greater benefit in each of the three cases.  Furthermore, Dey (1967) found that a delay in the administration of strychnine after a high dose vitamin C led to a parallel reduction in plasma vitamin C level and protection against strychnine (Table 3).

Although many of the studies in Tables 1 to 4 are old, it seems unlikely that administering a fixed dose of vitamin C and evaluating mortality were meaningfully different in the older days compared with modern methods.  It is noteworthy that dramatic effects by vitamin C against the toxicity of tetanus toxin and strychnine have been observed in diverse animal species ranging from fish and chicken to rat and mouse. Even though caution is needed in the extrapolation of animal study results to human subjects, the consistency in the effects in such diverse species gives support to the report by Jahan et al. (1984) who found that 1 g/day vitamin C protected against tetanus in human patients.
  
The doses of vitamin C used in the animal studies range up to 1-2 grams per kg body weight (Tables 1 to 4).  For a 70 kg person this would correspond to 70-140 grams. Only some 10 mg/day is needed to prevent scurvy, and the current recommendation of vitamin C intake in the USA is 90 mg/day. In this respect the doses in the animal studies are very high.

Lack of toxicity (Klenner, Levine)

References


Jahan K, Ahmad K, Ali MA (1984) Effect of ascorbic acid in the treatment of tetanus.  Bangladesh Med Res Counc Bull 10:24-28

Armour J, Tyml K, Lidington D, Wilson JX (2001) Ascorbate prevents microvascular dysfunction in the skeletal muscle of the septic rat.  J Appl Physiol 90:795-803  PubMed   

Benito E, Bosch MA (1997) Impaired phosphatidylcholine biosynthesis and ascorbic acid depletion in lung during lipopolysaccharide-induced endotoxaemia in guinea pigs. Mol Cell Biochem 175:117-23   PubMed  

Chakrabarti B, Banerjee S (1955) Dehydroascorbic acid level in blood of patients suffering from various infectious diseases.    Proc Soc Exp Biol Med 88:581-3   BM

Chakrabarti B, Banerjee S (1956) Studies on the functional activity of the adrenal cortes in some infectious diseases.  Indian J Med Res 44:211-215

Garcia R, Abarca S, Municio AM (1990) Adrenal gland function in reversible endotoxic shock. Circ Shock 30:365-74  PubMed  

Ghosh B (1939a) Vitamins and toxins. Part III. The effect of diphtheria toxin on vitamin C metabolism. J Indian Chemical Society 16: 241-246

Ghosh B (1939b) Vitamins and toxins. Part IV. The effect of tetanus toxin on vitamin C metabolism. J Indian Chemical Society 16: 657-662

Harde E (1934) Acide ascorbique (vitamine C) et intoxications [in French]. C R Acad Sci 119:618-20

Harris LJ, Passmore R, Oxon BM, et al. (1937) Influence of infection on vitamin C content of the tissues of animals.  Lancet 230:183-6 

Lyman CM, King CG (1936) The effect of diphtheria toxin on the vitamin C content of guinea pig tissues. J Pharmacol Exp Ther 56:209-15

Rojas C, Cadenas S, Herrero A, et al. (1996) Endotoxin depletes ascorbate in the guinea pig heart: protective effects of vitamins C and E against oxidative stress. Life Sci 59:649-57   PubMed 

Torrance CC (1940) Diphtherial intoxication and vitamin C content of the suprarenals of guinea pigs.  J Biol Chem 132:575-84 

Victor VM, Guayerbas N, de la Fuente M (2002) Changes in the antioxidant content of mononuclear leukocytes from mice with  endotoxin-induced oxidative stress. Mol Cell Biochem 229:107-11   PubMed 

Yamaguchi T, Hashizume T, Tanaka M, et al. (1997) Bilirubin oxidation provoked by endotoxin treatment is suppressed by feeding ascorbic acid in a rat mutant unable to synthesize ascorbic acid. Eur J Biochem 245:233-40  PubMed 


Table 1: Vitamin C and Tetanus Toxin

Study
Animal
Exposure
Vit C Control Difference Significance
P(1-tail)
No. in 
group
No. in 
group
Dey-1966
Rat
Tetanus toxin inj. 2×MLD
Vit C before or
simultaneusly with toxin
Animals 10 5
Mortality 0 5 -100% .0002
Vit C after signs
of tetanus appeared
Animals 15 5
Mortality 0 5 -100% .00004
Eichbaum-1977
Rat
Tetanus toxin inj. 2×MLD
Animals 5 5
Convulsions or death in 5 hours 0 5 -100% .002
Mortality in 6 days 3 5 -40% .1
Frezza-1957
Rats
Tetanus toxin inj
Tetanus toxin 10×MLD
Vit C 100 mg/kg
Animals 8 8
Survival time in hours
In parenthesis: the number of animals with the survival time
30;54;
60(2);
72(2);
78(2)
54(3);
60(2);
66(3)
+10%
in median
survival time
(66 vs. 60 h)
.065
Tetanus toxin 20×MLD
Vi
t C 100 mg/kg
Animals 8 8
Survival time in hours
In parenthesis: the number of animals with the survival time
21(3);
24;
27(2);
33;39
18;
21(2);
24(2)
27(3)
+6%
in median
survival time
(25.5 vs. 24 h)
.2
Tetanus toxin 10×MLD
Vit C 200 mg/kg
Animals 8 8
Survival time in hours
In parenthesis: the number of animals with the survival time
21;54;
72;84;
102(2);
114;
138
54(3);
60(2);
66(3)
+55%
in median
survival time
(93 vs. 60 h)
.007
Ghosh-1938
Guinea pig
Tetanus toxin inj. 1×MLD
100 mg ascorbic acid inj.
1 min after tetanus toxin
Animals 9 6
Mortality 5 6 -44% .047
100 mg neutralized ascorbic acid inj.
1 min after tetanus toxin
Animals 4 6
Mortality 4 6
100 mg ascorbic acid inj.
1 min before tetanus toxin
Animals 4 6
Mortality 2 6 0.07
50 mg/day ascorbic acid fed
for 6 days before tetanus toxin
Animals 6 6
Mortality 5 6 0.3
20 mg/day ascorbic acid inj.
for 6 days before tetanus toxin
Animals 6 6
Mortality 6 6


References to Table 1


Dey PK (1966) Efficacy of vitamin C in counteracting tetanus toxin toxicity. Naturwissenschaften 53:310  CH  BM

Eichbaum FW, Guedes AO, Palermo Neto J, Carvalho FV (1977)  Protecting effect of ascorbic acid in strychnine poisoning and in tetanus (experiments in fish, mice and rats).  Int J Vitam Nutr Res  Supplement 16:31-39

Frezza F (1957) Tetanus in hypervitaminosis C.   Vitaminologia (Rome) 15:65-73    Abstract

Ghosh B, Guha BC (1938) Vitamins and toxins. Part II. The effect of the administration of vitamin C to guinea-pigs injected with diphtheria and tetanus toxins. J Indian Chemical Society 15:443-448


Table 2: Vitamin C and Strychnine

Study
Animal
Exposure
Vit C Control Difference Significance
P(1-tail)
No. in 
group
No. in 
group
Dey-1965
Mice
Strychnine inj. 
Strychnine 2 mg/kg
Vit C 1000 mg/kg
Animals 10 20
Mortality 0 20 -100% <.000001
Strychnine 2 mg/kg
Vit C 2000 mg/kg
Animals 10 20
Mortality 0 20 -100% <.000001
Dey-1967
Mice
Strychnine inj
Strychnine 2 mg/kg
Vit C 50 mg/kg 
Animals1010
Mortality610-40%.022
Strychnine 2 mg/kg
Vit C 100 mg/kg 
Animals1010
Mortality410-60%.003
Strychnine 2 mg/kg
Vit C 500 mg/kg 
Animals1010
Mortality210-80%.0002
Strychnine 2 mg/kg
Vit C 1000 mg/kg 
Animals1010
Mortality010-100%.000003
Strychnine 2 mg/kg
Vit C 2000 mg/kg 
Animals1010
Mortality010-100%.000003
ED50 value for vitamin CED50=76 mg/kg
(95%CI: 19-149)

P(2-tail)=.0006
Test of trend
over vit C doses
in PROBIT analysis
Eichbaum-1977
Mice
Strychnine inj. 
Strychnine 0.35 mg/kg 
Vit C dose 1000 mg/kg
Animals4040
Mortality in 2 hours01
Strychnine 0.5 mg/kg 
Vit C dose 1000 mg/kg
Animals2525
Mortality in 2 hours14-75%.11
Strychnine 0.7 mg/kg 
Vit C dose 1000 mg/kg
Animals 40 40
Mortality in 2 hours 3 18 -83% .00007
Strychnine 1.0 mg/kg
Vit C dose 1000 mg/kg
Animals 25 25
Mortality in 2 hours 4 13 -69% .005
Strychnine 1.4 mg/kg
Vit C dose 1000 mg/kg
Animals 40 40
Mortality in 2 hours 18 30 -40% .004
Strychnine 2.0 mg/kg
Vit C dose 1000 mg/kg
Animals2525
Mortality in 2 hours2023-13%.14
Strychnine 2.8 mg/kg
Vit C dose 1000 mg/kg
Animals4040
Mortality in 2 hours3440-15%.007
LD50 values for strychnine: LD50=1.50 mg/kg
(95%CI: 1.33-1.70)
LD50=0.88 mg/kg
(95%CI: 0.78-0.99)
P(2-tail)<.000001
Test of vit C and
control difference
in PROBIT analysis
Eichbaum-1977
Fish
Strychnine in water
Strychnine 50 mg/l
Vit C dose 500 mg/l
Animals 120 120
Mortality in 2 hours 32 88 -63% <.000001
Strychnine 60 mg/l
Vit C dose 500 mg/l
Animals 120 120
Mortality in 2 hours 43 99 -56% <.000001
Jahan-1984
Chicken
Strychnine inj.
Strychnine 5 µg per chick
Vit C dose 30 mg/chick
Animals 15 15
Wings stretched 0 15 -100% <.000001
Mortality 0 0
Strychnine 10 µg per chick
Vit C dose 30 mg/chick
Animals 15 15
Extensor paralysis 3 15 -80% .000003
Mortality 0 12 -100% .000003


References to Table 2

Dey PK (1965) Protective action of lemon juice and ascorbic acid against lethality and convulsive property of strychnine.  Naturwissenschaften 52:164    CH    BM

Dey PK (1967)  Protective action of ascorbic acid and its precursors on the convulsive and lethal actions of strychnine.  Indian J Exp Biology  5(2):110-112

Eichbaum FW, Guedes AO, Palermo Neto J, Carvalho FV (1977)  Protecting effect of ascorbic acid in strychnine poisoning and in tetanus (experiments in fish, mice and rats).  Int J Vitam Nutr Res  Supplement 16:31-39

Jahan K, Ahmad K, Ali MA (1984) Effect of ascorbic acid in the treatment of tetanus. Bangladesh Med Res Counc Bull 10:24-28  


Table 3: Effect of the interval between vitamin C administration and strychnine administration (Dey 1967)

Time
(min)
Vitamin C
concentration
in plasma
Mortality
in the group
Effect on
Mortality
mg/100 mlµmol/l
156.03410/10-100%
302.41360/10-100%
601.04595/10-50%
1200.864910/100%
Control,
no vitamin C
administation
0.6638Not
tested

Vitamin C, 1000 mg/kg was administered intraperitoneally to mice, and strychnine, 2 mg/kg, was administered at the different time points and plasma vitamin C level was determined at the same time points.


References to Table 3

Dey PK (1967)  Protective action of ascorbic acid and its precursors on the convulsive and lethal actions of strychnine.  Indian J Exp Biology  5(2):110-112




Copyright:
© 2006-2008 Harri Hemilä. This text is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.  



Valid HTML 4.01 Transitional